HSAQ Logo

HSAQ Stock Forecast: Health Sciences Acquisitions Corporation 2 Price Predictions for 2026

Home โ€บ Stocks โ€บ United States | NASDAQ | |

$4.66

-0.14 (-2.92%)

HSAQ Stock Forecast 2026-2027

$4.66
Current Price
$52.25M
Market Cap
0 Ratings
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to HSAQ Price Targets

N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A

HSAQ Price Momentum

+4.7%
1 Week Change
+3.3%
1 Month Change
-11.6%
1 Year Change
+12.3%
Year-to-Date Change
-24.4%
From 52W High of $6.16
+111.8%
From 52W Low of $2.20
๐Ÿ“Š TOP ANALYST CALLS

Did HSAQ Make This Month's Elite Buy List?

We don't follow just any analyst โ€” only the top 3% with a proven track record make our cut. See if HSAQ is one of their latest high-conviction picks.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Latest HSAQ Stock Price Targets & Analyst Predictions

HSAQ has shown a year-to-date change of 12.3% and a 1-year change of -11.6%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for HSAQ. Please refer to the price chart above for recent performance and trends.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

HSAQ Analyst Ratings

0
Buy
0
Hold
0
Sell

HSAQ Price Target Range

Low
N/A
Average
N/A
High
N/A
Current: $4.66

Latest HSAQ Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for HSAQ.

Date Firm Analyst Rating Change Price Target

Health Sciences Acquisitions Corporation 2 (HSAQ) Competitors

The following stocks are similar to HSAQ based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Health Sciences Acquisitions Corporation 2 (HSAQ) Financial Data

Valuation Metrics

Market Cap $52.25M
Enterprise Value $0
P/E Ratio N/A
PEG Ratio N/A
Price/Sales N/A

Growth & Margins

Revenue Growth (YoY) N/A
Gross Margin N/A
Operating Margin N/A
Net Margin N/A
EPS Growth N/A

Financial Health

Cash/Price Ratio N/A
Current Ratio 0.8x
Debt/Equity 0.0x
ROE -4.5%
ROA -4.0%
๐Ÿ’ก SKIP THE NOISE

97% of Analyst Ratings Go Nowhere

We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ€” tracked and updated every Monday and Thursday.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Health Sciences Acquisitions Corporation 2 logo

Health Sciences Acquisitions Corporation 2 (HSAQ) Business Model

About Health Sciences Acquisitions Corporation 2

What They Do

N/A

Business Model

N/A

Additional Information

N/A

Company Information

Sector

Industry

Employees

0

CEO

Country

United States

IPO Year

2020

Website

Health Sciences Acquisitions Corporation 2 (HSAQ) Latest News & Analysis

Latest News

HSAQ stock latest news image
Quick Summary

Health Sciences Acquisitions Corporation 2, a SPAC sponsored by RTW Investments, completed its business combination on January 26, 2023.

Why It Matters

The completion of the business combination may enhance market confidence and liquidity for the company, potentially impacting stock performance and investor sentiment positively.

Source: GlobeNewsWire
Market Sentiment: Neutral
HSAQ stock latest news image
Quick Summary

Medtronic is collaborating to develop BackBeat Cardiac Neuromodulation Therapyโ„ข for hypertension treatment in cardiac pacemaker patients.

Why It Matters

The collaboration with Medtronic signals innovation in hypertension treatment, potentially increasing market share and revenue for companies involved, impacting stock performance positively.

Source: GlobeNewsWire
Market Sentiment: Neutral

Frequently Asked Questions About HSAQ Stock

What is Health Sciences Acquisitions Corporation 2's (HSAQ) stock forecast for 2026?

Analyst forecasts for Health Sciences Acquisitions Corporation 2 (HSAQ) are not currently available. The stock is trading at $4.66.

Is HSAQ stock a good investment in 2026?

Analyst ratings for HSAQ are not currently available. The stock is currently trading at $4.66. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.

What is the long-term price prediction for HSAQ stock?

Price predictions from Wall Street analysts for HSAQ are not currently available. The stock is trading at $4.66.

What is Health Sciences Acquisitions Corporation 2's business model?

N/A

What is the highest forecasted price for HSAQ Health Sciences Acquisitions Corporation 2?

Price targets from Wall Street analysts for HSAQ are not currently available. The stock is trading at $4.66.

What is the lowest forecasted price for HSAQ Health Sciences Acquisitions Corporation 2?

Price targets from Wall Street analysts for HSAQ are not currently available. The stock is trading at $4.66.

What is the overall HSAQ consensus from analysts for Health Sciences Acquisitions Corporation 2?

Analyst ratings for HSAQ are not currently available. The stock is trading at $4.66.

How accurate are HSAQ stock price projections?

Stock price projections, including those for Health Sciences Acquisitions Corporation 2, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.

Important Disclaimer

The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Last updated: January 13, 2026 4:13 PM UTC
Serious About Growing Your Portfolio?

We highlight 2 high-upside stocks each month – no fluff.

Missedย NVDA?
Donโ€™t Miss the Next One.

Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ€” for free.